Education
About Us
Working with TipRanks
Follow Us
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
RESEARCH TOOLSreports
8189 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.65
Previous CloseN/A
Volume305.00K
Average Volume (3M)686.67K
Market Cap
HK$853.76M
Enterprise ValueHK$423.72M
Total Cash (Recent Filing)HK$92.73M
Total Debt (Recent Filing)¥110.53M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,436,400,000
10 Day Avg. Volume422,000
30 Day Avg. Volume686,666
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)4.60
Price to Sales (P/S)0.00
P/FCF Ratio-15.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8189 FAQ
What was Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H lowest stock price was HK$0.07 and its highest was HK$0.65 in the past 12 months.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap is HK$853.76M.
When is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date is May 13, 2025 which is 37 days ago.
How were Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s earnings last quarter?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H released its earnings results on Mar 31, 2025. The company reported -HK$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.014.
Is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H overvalued?
According to Wall Street analysts Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price is currently Overvalued.
Does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H pay dividends?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H does not currently pay dividends.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H have?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H has 1,436,400,000 shares outstanding.
What happened to Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H reported an EPS of -HK$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.128%.
Which hedge fund is a major shareholder of Tianjin TEDA Biomedical Engineering Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
426.31%
12-Months-Change
Fundamentals
Return on Equity
-81.86%
Trailing 12-Months
Asset Growth
5.98%
Trailing 12-Months
Company Description
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) is a company engaged in the biomedical sector, focusing on the research, development, and commercialization of biotechnology products. The company primarily operates within the fields of medical and health products, offering a range of services and products designed to improve healthcare outcomes.
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Shandong Weigao Group Medical Polymer Co
―
Huazhu Group Ltd
―
CSPC Pharmaceutical Group
―